Experienced in Leg or Foot Amputation

Dr. Christie M. Ballantyne

Cardiology
Baylor College Of Medicine
7200 Cambridge St, 
Houston, TX 
Accepting New Patients
Offers Telehealth
Experienced in Leg or Foot Amputation
Baylor College Of Medicine
7200 Cambridge St, 
Houston, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Christie Ballantyne is a Cardiologist in Houston, Texas. Dr. Ballantyne is rated as an Experienced provider by MediFind in Leg or Foot Amputation. His top areas of expertise are Familial Hypertriglyceridemia, High Cholesterol, Atherosclerosis, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery. Dr. Ballantyne is currently accepting new patients.

His clinical research consists of co-authoring 843 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Leg or Foot Amputation.

Specialties
Cardiology
Licenses
Internal Medicine in TX
Languages Spoken
English
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

BAYLOR COLLEGE OF MEDICINE
7200 Cambridge St, Houston, TX 77030

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Severe Hypertriglyceridemia
A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Severe Hypertriglyceridemia
Enrollment Status: Completed
Publish Date: October 03, 2025
Intervention Type: Drug
Study Drug: ARO-APOC3
Study Phase: Phase 2
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
Enrollment Status: Active_not_recruiting
Publish Date: July 09, 2025
Intervention Type: Drug
Study Drug: TQJ230
Study Phase: Phase 3
A Double-blind, Placebo-controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-ANG3 in Adults With Mixed Dyslipidemia
A Double-blind, Placebo-controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-ANG3 in Adults With Mixed Dyslipidemia
Enrollment Status: Completed
Publish Date: November 07, 2024
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

843 Total Publications

A Proposal to Elevate the Status of Troponin and B-Type Natriuretic Peptides as Atherosclerotic Cardiovascular Disease Risk Enhancers.
A Proposal to Elevate the Status of Troponin and B-Type Natriuretic Peptides as Atherosclerotic Cardiovascular Disease Risk Enhancers.
Journal: Circulation
Published: September 02, 2025
Similar Doctors
Experienced in Leg or Foot Amputation
Dr. Vijay Nambi
Cardiology
Experienced in Leg or Foot Amputation
Dr. Vijay Nambi
Cardiology

Baylor College Of Medicine

7200 Cambridge St, Suite 1, 
Houston, TX 
 (0.1 miles away)
713-798-2500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Vijay Nambi is a Cardiologist in Houston, Texas. Dr. Nambi is rated as a Distinguished provider by MediFind in Leg or Foot Amputation. His top areas of expertise are Atherosclerosis, Heart Failure, Peripheral Artery Disease, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery. Dr. Nambi is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ballantyne's expertise for a condition
ConditionClose
View All 9 Elite Conditions
View All 10 Advanced Conditions
View All 18 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile